Intrathymic injection of donor splenocytes plus systemic antilymphocyte serum or antilymphocyte serum alone prolongs cardiac allograft survival and inhibits graft arteriosclerosis in the Lewis-to-F344 chronic rejection model

Transplant Proc. 1995 Jun;27(3):2112-4.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antilymphocyte Serum / therapeutic use
  • Chronic Disease
  • Coronary Artery Disease / prevention & control
  • Graft Occlusion, Vascular / prevention & control*
  • Graft Rejection / prevention & control
  • Graft Survival*
  • Heart Transplantation / immunology*
  • Immunosuppression Therapy / methods*
  • Male
  • Rats
  • Rats, Inbred F344
  • Rats, Inbred Lew
  • Spleen / immunology
  • Thymus Gland / immunology
  • Tissue Donors

Substances

  • Antilymphocyte Serum